Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial

Ticagrelor has a greater antiplatelet efficacy than clopidogrel but may be accompanied by an increased risk of bleeding. This study evaluated the antiplatelet effect and pharmacokinetic profile of low-dose ticagrelor in healthy Chinese volunteers. Thirty healthy subjects were randomized to receive s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pan, Gu, Ying, Yang, Yawei, Chen, Lizhi, Liu, Junmei, Gao, Lihong, Qin, Yongwen, Cai, Quancai, Zhao, Xianxian, Wang, Zhuo, Ma, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995486/
https://www.ncbi.nlm.nih.gov/pubmed/27554803
http://dx.doi.org/10.1038/srep31838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995486/
https://www.ncbi.nlm.nih.gov/pubmed/27554803
http://dx.doi.org/10.1038/srep31838

Ejemplares similares